There were other reports that CALML3 was highly expressed in normal differentiation of epithelial tissues, such as breast, thyroid, prostate, kidney and skin, and also significantly downregulated in breast tumours, oral cancers and skin cancers39,43–45. This evidence concerns the gene CALML3 and lip and oral cavity carcinoma.